Gaurav Aggarwal
Director/Board Member at UNICYCIVE THERAPEUTICS, INC.
Net worth: 7 013 $ as of 2024-04-29
Profile
Gaurav Aggarwal is currently serving as an Independent Director at Geron Corp., Unicycive Therapeutics, Inc., and as the Managing Partner at Vivo Capital LLC.
Previously, he held positions as a Director at Vela Pharmaceuticals, Inc., Sierra Oncology, Inc., Piramed Ltd., Alvine Pharmaceuticals, Inc., Hyperion Therapeutics, Inc., NextWave Pharmaceuticals, Inc., Microlin Bio, Inc., FlowCardia, Inc., Auspex Pharmaceuticals, Inc., Patricia Industries AB, J.P.
Morgan Partners LLC, OCERA Therapeutics LLC, KBL Healthcare Ventures, Panorama Capital LLC, and Wasserstein Perella & Co., Inc. Dr. Aggarwal obtained his undergraduate degree from Cornell University in 1994 and his doctorate from Columbia University College of Physicians & Surgeons in 2000.
His current job(s) include Independent Director at Geron Corp., Independent Director at Unicycive Therapeutics, Inc., and Managing Partner at Vivo Capital LLC.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GERON CORPORATION
0.00% | 2024-05-08 | 1,970 ( 0.00% ) | 7 013 $ | 2024-04-29 |
Gaurav Aggarwal active positions
| Companies | Position | Start |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Director/Board Member | 2023-03-07 |
| GERON CORPORATION | Director/Board Member | 2023-11-27 |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 2016-09-30 |
Former positions of Gaurav Aggarwal
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Director/Board Member | 2022-06-30 |
| OCERA THERAPEUTICS INC | Corporate Officer/Principal | 2016-10-06 |
Patricia Industries AB
 Patricia Industries AB Investment ManagersFinance Patricia Industries AB (Patricia Industries) is a private equity subsidiary of Investor AB founded in 1972. The firm is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 2013-11-30 |
Vela Pharmaceuticals, Inc.
 Vela Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vela Pharmaceuticals, Inc. develops medicines related to the nervous system. It develops and manufactures medicines for treatment of menopausal hot flashes, irritable bowel syndrome and for the treatment of depression. The company was founded in 1998 and is headquartered at Ewing, NJ. | Director/Board Member | 2013-11-12 |
| HYPERION THERAPEUTICS INC | Director/Board Member | 2013-04-07 |
Training of Gaurav Aggarwal
| Cornell University | Undergraduate Degree |
| Columbia University College of Physicians & Surgeons | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Private companies | 17 |
|---|---|
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners LLC is a private equity firm founded in 1984. The firm headquartered located in New York City. | Finance |
KBL Healthcare Ventures
 KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare Ventures (KBL Healthcare) is a venture capital firm founded in 1991 by Zachary C. Berk and Marlene R. Krauss. The firm is headquartered in New York. | Finance |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Commercial Services |
Vela Pharmaceuticals, Inc.
Vela Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vela Pharmaceuticals, Inc. develops medicines related to the nervous system. It develops and manufactures medicines for treatment of menopausal hot flashes, irritable bowel syndrome and for the treatment of depression. The company was founded in 1998 and is headquartered at Ewing, NJ. | Health Technology |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Finance |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Health Technology |
| Wasserstein Perella & Co., Inc. | |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Patricia Industries AB
Patricia Industries AB Investment ManagersFinance Patricia Industries AB (Patricia Industries) is a private equity subsidiary of Investor AB founded in 1972. The firm is headquartered in Stockholm, Sweden. | Finance |
Investor Growth Capital Asia Ltd.
 Investor Growth Capital Asia Ltd. Investment ManagersFinance Investor Growth Capital Asia Ltd. (IGC Asia), with offices in Hong Kong, Tokyo and Beijing, is the wholly-owned venture capital arm of Investor AB (SSE: INVE), which was founded in 1916 by the Wallenberg family and is headquartered in Stockholm. IGC was established in 1995. They are organized in three units: Investor Growth Capital Asia, Investor Growth Capital Europe and Investor Growth Capital US. Other IGC offices are in New York, California and Amsterdam. The Hog Kong office opened in 2000. | Finance |
- Stock Market
- Insiders
- Gaurav Aggarwal
